KCK MedTech

Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

Sonex Health, LLC, founded in 2014 and based in Rochester, Minnesota, specializes in developing micro-invasive surgical devices aimed at enhancing patient care and reducing healthcare costs. The company is known for its SX-One MicroKnife featuring Meerkat Technology, which enables a novel approach to treating carpal tunnel syndrome through an ultrasound-guided carpal tunnel release procedure. This innovative technique allows surgeries to be performed in outpatient settings rather than operating rooms, facilitating quicker patient recovery and improved cosmetic outcomes. The SX-One MicroKnife utilizes a micro-incision significantly smaller than traditional methods, often requiring only a small adhesive bandage for closure. This results in a low-trauma surgical experience that allows patients to begin rehabilitation immediately, minimizing downtime and promoting a swift return to daily activities. Sonex Health is dedicated to refining surgical practices to address important healthcare challenges effectively.

Allotex, Inc. is an ophthalmic biologics and device company based in Boston, Massachusetts, established in 2013. The company specializes in developing innovative contact lenses and therapeutic solutions aimed at addressing refractive vision issues, including presbyopia, hyperopia, and myopia. Allotex utilizes precisely-shaped human corneal allografts in conjunction with a compact excimer laser system to create permanent, living contact lenses or lens inserts. This approach enables medical professionals to provide minimally invasive treatment options for various refractive procedures, enhancing patient outcomes in vision correction.

Candesant Biomedical develops innovative solutions for excessive sweating and hyperhidrosis. Founded in 2015 and headquartered in San Francisco, California, the company focuses on a proprietary medical device known as CDX-101. This non-invasive technology utilizes water-activated principles to deliver targeted energy to active sweat glands, effectively inactivating them without discomfort for patients. By controlling the interaction between alkali metals and water, Candesant's device aims to reduce excessive sweating and inhibit bacterial growth, providing a significant improvement in quality of life for individuals affected by this condition.

Revamp Medical, founded in 2016, focuses on addressing the urgent unmet needs of patients suffering from acute heart failure, a condition that leads to over one million annual hospital admissions in the United States and incurs significant healthcare costs. The company has developed the Doraya™ catheter, a patented device designed to regulate vascular hemodynamics in these patients. This innovative solution targets issues such as diuretic resistance by managing preload and reducing central venous pressure, ultimately enhancing the efficacy of diuretics and facilitating progressive decongestion. Revamp Medical is backed by a team of experienced professionals with a strong background in medical technology startups, positioning the company to deliver an easily adoptable treatment option that addresses a critical gap in heart failure care.